Altered role of C-type natriuretic peptide-activated pGC-cGMP-PDE3-cAMP signaling in hyperthyroid beating rabbit atria

Regulatory Peptides

Volumn 142, Issue 3, 2007, Pages 123-130

  Wen, Jin Fu ^a,b   Quan, He Xiu ^a,b   Zhou, Guang Hai ^a,b   Cho, Kyung Woo ^a,b  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

Atrial function; Atrial natriuretic peptide; cAMP; cGMP; Hyperthyroidism; Phosphodiesterase 3

Indexed keywords

CYCLIC AMP; CYCLIC GMP; GUANYLATE CYCLASE; MILRINONE; NATRIURETIC PEPTIDE TYPE C; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHODIESTERASE III;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EFFUSION; ENZYME BLOOD LEVEL; ENZYME REGULATION; EUTHYROIDISM; HEART ATRIUM; HEART ATRIUM CONTRACTILITY; HEART ATRIUM FUNCTION; HEART STROKE VOLUME; HYPERTHYROIDISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; PULSE PRESSURE; RABBIT; SIGNAL TRANSDUCTION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CYCLIC AMP; CYCLIC GMP; ENZYME ACTIVATION; GUANYLATE CYCLASE; HEART ATRIA; HYPERTHYROIDISM; MYOCARDIUM; NATRIURETIC PEPTIDE, C-TYPE; RABBITS; SIGNAL TRANSDUCTION;

ORYCTOLAGUS CUNICULUS;

EID: 34250202880     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.02.004     Document Type: Article

References (28)

1. Wen J.F., Cui X., Jin J.Y., Kim S.M., Kim S.Z., Kim S.H., Lee H.S., and Cho K.W. High and low gain switches for regulation of cAMP efflux concentration. Distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria. Circ Res 94 (2004) 936-943
2. 2+ current in guinea-pig ventricular cells. J Physiol 443 (1991) 387-404
3. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268 (1993) 26286-26295
4. Kirstein M., Rivet-Bastide M., Hatem S., Benardeau A., Mercadier J.-J., and Fischmeister R. Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95 (1995) 794-802
5. Herring N., Zaman J.A.B., and Paterson D.J. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway. Am J Physiol 281 (2001) H2318-H2327
6. 2+ channel current in human atrial myocytes. J Physiol 533 (2001) 329-340
7. Vesely D.L. Atrial natriuretic peptides in pathophysiological diseases. Cardiovasc Res 51 (2001) 647-658
8. Lee S.J., Kim S.Z., Cui X., Kim S.H., Lee K.S., Chung Y.J., and Cho K.W. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling. Am J Physiol 278 (2000) H208-H221
9. Brusq J.-M., Mayoux E., Guigui L., and Kirilovsky J. Effects of C-type natriuretic peptide on rat cardiac contractility. Br J Pharmacol 128 (1999) 206-212
10. Beaulieu P., Cardinal R., Page P., Francoeur F., Trembly J., and Lambert C. Positive chronotropic and inotropic effects of C-type natriuretic peptide in dogs. Am J Physiol 273 (1997) H1933-H1940
11. Hirose M., Furukawa Y., Kurogouchi F., Nakajima K., Miyashita Y., and Chiba S. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations. J Pharmacol Exp Ther 286 (1998) 70-76
12. Wollert K.C., Yurokova S., Kilic A., Begrow F., Fiedler B., Gambaryan S., Walter U., Lohmann S.M., and Kuhn M. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I. Br J Pharmacol 140 (2003) 1227-1236
13. Nir A., Zhang D.F., Fixler R., Burnett Jr. J.C., Eilam Y., and Hasin Y. C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes. Eur J Pharmacol 412 (2001) 195-201
14. Klein I., and Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 344 (2001) 501-509
15. Cho K.W., Kim S.H., Kim C.H., and Seul K.H. Mechanical basis of atrial natriuretic peptide secretion in beating atria: atrial stroke volume and ECF translocation. Am J Physiol 268 (1995) R1129-R1136
16. 2+-independent cAMP inhibition of ANP release in beating rabbit atria. Am J Physiol 282 (2002) R1477-R1489
17. Chen H.H., and Burnett Jr. J.C. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 32 Suppl 3 (1998) S22-S28
18. Engel S., Yan L., Weiss H., and Scholz P. Negative functional effects of cGMP mediated by cGMP protein kinase are reduced in T4 cardiac myocytes. Eur J Pharmacol 421 (2001) 23-30
19. 2+ current regulation in cardiac cells. Life Sci 48 (1991) 2365-2376
20. Cui X., Wen J.F., Jin H., Li D., Jin J.Y., Kim S.H., Kim S.Z., Lee H.S., and Cho K.W. Subtype-specific roles of cAMP phosphodiesterases in regulation of atrial natriuretic peptide release. Eur J Pharmacol 451 (2002) 295-302
21. Straznicka M., Leone Jr. R.J., Scholz P.M., and Weiss H.R. Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy. J Surg Res 76 (1998) 61-66
22. Gerbes A.L., and Nemer M. Detection of C-type natriuretic peptide compared with brain and atrial natriuretic peptide transcripts in human heart by the polymerase chain reaction. Clin Invest 71 (1993) 672
23. Nunez D.J., Dickson M.C., and Brown M.J. Natriuretic peptide receptor mRNAs in the rat and human heart. J Clin Invest 90 (1992) 1966-1971
24. Potter L.R. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: Dephosphorylation is a mechanism of desensitization. Biochemistry 37 (1998) 2422-2429
25. Potter L.R., and Hunter T. Identification and characterization of the major phosphorylation sites of the B-type natriuretic peptide receptor. J Biol Chem 273 (1998) 15533-15539
26. Degerman E., Belfrage P., and Manganiello V.C. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 272 (1997) 6823-6826
27. Movesian M.A. Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure. Exp Opin Invest Drugs 9 (2000) 1-11
28. Kohno M., Murakawa K., Yasunari K., Nishizawa Y., Morii H., and Takeda T. Circulating atrial natriuretic peptides in hyperthyroidism and hypothyroidism. Am J Med 83 (1987) 648-652